WiseGuyReports.com adds“Early Toxicity Testing 2016 Market
Share,Size,Trends and Forecast to 2022 Market Research Report”reports to its database.
COMPLETE
REPORT DETAILS @
https://www.wiseguyreports.com/reports/world-blood-testing-technologies-market-opportunities-and-forecasts-2014-2022
Testing of blood is one of the oldest and most
widely used techniques to rule out the presence of any disease. Blood tests are
used to assure the biochemical and physiological well-being of the humans. They
are also used to confirm the proper functioning of vital organs such as liver,
kidney and thyroid and to understand the effectiveness of given therapeutics.
The technological innovations along with consistent demand for better blood
testing technologies have intensified the global competition. The market is
growing owing to the burgeoning demand for point-of-care and minimally invasive
testing devices.
The major factors fuelling the global blood testing
technologies market growth are high incidence of lifestyle diseases, cancer,
infectious diseases and genetic disorders. Large pool of old age population
along with increased public and private spending on diagnostics and research
are other significant factors leading to market growth. Rising number of
diagnostic centers, hospitals and emergence of home care diagnostics have
opened lucrative avenues in the blood testing market. However, lack of
awareness, reluctance to adopt newer technologies and unavailability of skilled
labor are likely to restrain the market growth.
For more information or any query mail at
sales@wiseguyreports.com
The global blood testing technologies market is segmented on the basis of
type, technology, end user and geography. On the basis of type, the market is
segmented into Complete Blood Count (CBC), Basic Metabolic Panel (BMP) such as
blood glucose test, electrolyte test and kidney test; blood enzyme tests such
as Troponin and Creatine Kinase; tests to assess heart disease risk such as
lipoprotein panel and cholesterol test and blood clotting tests; and others
such as Erythrocyte Sedimentation Rate (ESR). On the basis of technology, the
market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA),
Chemiluminescent immunoassay (CLIA), Radioimmunoprecipitation assay (RIPA),
Nucleic Acid Amplification Test (NAAT), Polymerase Chain Reaction (PCR),
Transcription-mediated Amplification (TMA), Enzyme Immunoassay (EIA),
Immunofluorescence Assay (IFA), Next Generation Sequencing (NGS) and Western
Blot Test. The market is segmented on the basis of end user into hospitals and
clinics, diagnostic centers and homes. Geographically, the market is segmented
across four regions viz., North America, Europe, Asia-Pacific and LAMEA.
Few strategies adopted by industrial players are collaborations and
acquisitions. For instance Roche Diagnostics, in Dec 2014, acquired Ariosa
Diagnostics, to enter into non-invasive prenatal test (NIPT) and cell-free DNA
testing services markets. Ariosa’s proprietary Harmony Prenatal Test is a blood
test that measures fetal cfDNA found in maternal blood. Recently, Philips has
entered into collaboration agreement with Janssen Pharmaceutica N.V., to
develop a handheld blood test intended to be used in neuropsychiatric care. The
companies profiled in the report include Abbott Laboratories, F. Hoffmann-La
Roche AG, Beckman Coulter Inc., Siemens AG., Thermo Fisher Scientific Inc.,
Becton Dickinson and Company, bioMérieux SA, Koninklijke Philips N.V., Alere
Inc. and Medtronic plc.
KEY
MARKET BENEFITS
Comprehensive analysis of factors that drive and restrict the growth of
the global blood testing technologies market is provided
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing Market - Opportunities
An in-depth analysis of key segments of the market demonstrates the types of blood testing equipment along with the technologies and end-users in blood testing market
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise blood testing technologies market conditions are comprehensively analyzed in this report
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing Market - Opportunities
An in-depth analysis of key segments of the market demonstrates the types of blood testing equipment along with the technologies and end-users in blood testing market
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise blood testing technologies market conditions are comprehensively analyzed in this report
REQUEST
FOR TABLE OF CONTENTS @ https://www.wiseguyreports.com/request-toc/world-blood-testing-technologies-market-opportunities-and-forecasts-2014-2022
KEY
MARKET SEGMENT:
The global blood testing technologies market is segmented below:
Global
Blood Testing Technologies Market - By Type
Complete Blood Count (CBC)
Basic Metabolic Panel (BMP)
Blood Glucose Test
Electrolyte Test
Kidney Test
Blood Enzyme Tests
Troponin
Creatine Kinase
Tests To Assess Heart Disease Risk
Lipoprotein Panel and Cholesterol Test
Blood Clotting Tests
Others
Erythrocyte Sedimentation Rate (ESR)
Basic Metabolic Panel (BMP)
Blood Glucose Test
Electrolyte Test
Kidney Test
Blood Enzyme Tests
Troponin
Creatine Kinase
Tests To Assess Heart Disease Risk
Lipoprotein Panel and Cholesterol Test
Blood Clotting Tests
Others
Erythrocyte Sedimentation Rate (ESR)
Global
Blood Testing Technologies Market - By Technology
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescent immunoassay (CLIA)
Radioimmunoprecipitation assay (RIPA)
Nucleic Acid Amplification Test (NAAT)
Polymerase Chain Reaction (PCR)
Transcription-Mediated Amplification (TMA)
Enzyme Immunoassay (EIA)
Immunofluorescence Assay (IFA)
Next Generation Sequencing (NGS)
Western Blot Test
Chemiluminescent immunoassay (CLIA)
Radioimmunoprecipitation assay (RIPA)
Nucleic Acid Amplification Test (NAAT)
Polymerase Chain Reaction (PCR)
Transcription-Mediated Amplification (TMA)
Enzyme Immunoassay (EIA)
Immunofluorescence Assay (IFA)
Next Generation Sequencing (NGS)
Western Blot Test
Global
Blood Testing Technologies Market - By End User
Hospitals and Clinics
Diagnostic Centers
Homes
Diagnostic Centers
Homes
Global
Blood Testing Technologies Market - By Geography
North America
Europe
Asia-Pacific
LAMEA
Europe
Asia-Pacific
LAMEA
RESEARCH METHODOLOGY
With collective industry experience of about 200 years of its analysts
and experts, Allied Market Research (AMR) encompasses most infallible research
methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest
details for the purpose of our market estimates and forecasts. Our approach
helps in building greater market consensus view for size, shape and industry
trends within each industry segment. We carefully factor in industry trends and
real developments for identifying key growth factors and future course of the
market. Our research proceeds are the resultant of high quality data, expert
views and analysis and high value independent opinions. Our research process is
designed to deliver balanced view of the global markets and allow stakeholders
to make informed decisions.
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that
can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well
audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of
marketplace
CONTINUE…….
For more information or any query mail at sales@wiseguyreports.com
Contact
Us:
NORAH TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph:
+44 208 133 9349 (UK)
